Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial

Huang, YW; Qin, A; Fang, JN; Wang, TF; Tsai, CW; Lin, KC; Teng, CL; Larouche, R

Huang, YW; Teng, CL (通讯作者)，PharmaEssentia Corp, 13F,3 Pk St, Taipei 115, Taiwan.;Huang, YW (通讯作者)，Taipei Med Univ, Coll Med, Sch Med, Div Gastroenterol & Hepatol,Dept Internal Med, 252 Wuxing St, Taipei 110, Taiwan.;Huang, YW; Teng, CL (通讯作者)，Taipei Med Univ Hosp, Clin Res Ctr, 252 Wuxing St, Taipei 110, Taiwan.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022; 88 (5): 2396

Abstract

Aims Ropeginterferon alfa-2b is a novel, long-acting pegylated interferon alfa-2b. We aimed to evaluate its safety, pharmacokinetics (PK) and pharmaco......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索